In future experiments, it would be helpful to evaluate the efficacy of pVAX1-MYR1 immunization by comparing the brain tissue cyst burden in vaccinated and control groups by using low virulence strains of T. gondii and analyzing the potential immune response mechanisms involved. The gene discussed is MYO1B; the disease is cyst.